The use of the ILADS method in the treatment of Lyme disease is incompatible with current medical knowledge and violates patient rights, the Patient Ombudsman's position was confirmed by the Regional Administrative Court in Warsaw.
According to the Office of the Patient Ombudsman, on April 18, 2024, the Provincial Administrative Court in Warsaw dismissed a complaint by one of the medical entities against a decision (dated October 2023) by the Patient Ombudsman recognizing the use of practices that violate the patient's collective right to use the ILADS method on patients for Lyme disease.
It should be recalled that the above method assumes, among other things, the existence of "chronic" Lyme disease and its treatment fraught with many dangerous side effects - using long-term, months-long antibiot...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
